Medicare to Cover Ozempic and Other Weight Loss Drugs, Lowering Costs
TL;DR Summary
President Trump announced a deal to expand Medicare coverage for weight-loss drugs like Ozempic and Wegovy, reducing costs for beneficiaries and potentially increasing federal spending by at least $35 billion from 2026 to 2034, amid ongoing concerns about the national debt.
- Trump punches new $35 billion hole in national debt with deal for Medicare to cover your Ozempic Fortune
- Certain obesity drugs will cost as little as $149 and Medicare will start covering them under White House deals CNN
- Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage CNBC
- Ozempic Is About to Go on Sale The Atlantic
- The potential impact of lowering the cost of weight loss drugs PBS
Reading Insights
Total Reads
1
Unique Readers
2
Time Saved
2 min
vs 3 min read
Condensed
92%
487 → 41 words
Want the full story? Read the original article
Read on Fortune